GeneDx Historical Income Statement

WGS Stock   99.13  3.28  3.42%   
Historical analysis of GeneDx Holdings income statement accounts such as Interest Income of 3.1 M, Depreciation And Amortization of 30.9 M, Interest Expense of 2.7 M or Selling General Administrative of 142 M can show how well GeneDx Holdings Corp performed in making a profits. Evaluating GeneDx Holdings income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of GeneDx Holdings's future profits or losses.
 
Covid
Financial Statement Analysis is much more than just reviewing and examining GeneDx Holdings Corp latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether GeneDx Holdings Corp is a good buy for the upcoming year.
  
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in GeneDx Holdings Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

About GeneDx Income Statement Analysis

GeneDx Holdings Corp Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to GeneDx Holdings shareholders. The income statement also shows GeneDx investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

GeneDx Holdings Income Statement Chart

At this time, GeneDx Holdings' Reconciled Depreciation is comparatively stable compared to the past year.

Total Revenue

Total revenue comprises all receipts GeneDx Holdings Corp generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of GeneDx Holdings Corp. It is also known as GeneDx Holdings overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.
Most accounts from GeneDx Holdings' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into GeneDx Holdings Corp current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in GeneDx Holdings Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
At this time, GeneDx Holdings' Reconciled Depreciation is comparatively stable compared to the past year.
 2022 2024 2025 (projected)
Depreciation And Amortization63.0M38.8M30.9M
Interest Income2.5M2.9M3.1M

GeneDx Holdings income statement Correlations

-0.27-0.46-0.68-0.62-0.61-0.65-0.2-0.620.290.260.5-0.580.28-0.41-0.65-0.330.25-0.310.26-0.140.660.66
-0.270.740.620.410.390.750.520.29-0.08-0.22-0.40.06-0.120.080.320.67-0.24-0.39-0.22-0.52-0.69-0.69
-0.460.740.880.850.860.67-0.110.8-0.72-0.79-0.890.66-0.720.710.820.97-0.790.23-0.79-0.66-0.37-0.37
-0.680.620.880.90.810.67-0.050.81-0.61-0.66-0.840.76-0.650.650.840.81-0.650.28-0.66-0.26-0.46-0.46
-0.620.410.850.90.960.45-0.330.97-0.83-0.81-0.910.93-0.80.880.990.86-0.80.6-0.81-0.3-0.31-0.31
-0.610.390.860.810.960.46-0.360.99-0.88-0.86-0.940.9-0.840.920.980.88-0.860.62-0.86-0.45-0.29-0.29
-0.650.750.670.670.450.460.520.36-0.12-0.16-0.380.2-0.080.140.410.5-0.17-0.05-0.15-0.25-0.68-0.68
-0.20.52-0.11-0.05-0.33-0.360.52-0.420.740.670.46-0.580.74-0.69-0.38-0.240.66-0.670.680.21-0.74-0.74
-0.620.290.80.810.970.990.36-0.42-0.89-0.86-0.930.95-0.860.941.00.83-0.850.66-0.86-0.35-0.26-0.26
0.29-0.08-0.72-0.61-0.83-0.88-0.120.74-0.890.970.91-0.890.97-0.99-0.86-0.780.97-0.710.970.52-0.18-0.18
0.26-0.22-0.79-0.66-0.81-0.86-0.160.67-0.860.970.96-0.830.99-0.95-0.84-0.851.0-0.531.00.64-0.12-0.12
0.5-0.4-0.89-0.84-0.91-0.94-0.380.46-0.930.910.96-0.870.94-0.93-0.92-0.90.95-0.470.950.570.150.15
-0.580.060.660.760.930.90.2-0.580.95-0.89-0.83-0.87-0.870.940.950.69-0.810.77-0.83-0.15-0.05-0.05
0.28-0.12-0.72-0.65-0.8-0.84-0.080.74-0.860.970.990.94-0.87-0.96-0.83-0.780.98-0.580.990.55-0.18-0.18
-0.410.080.710.650.880.920.14-0.690.94-0.99-0.95-0.930.94-0.960.920.77-0.940.74-0.95-0.440.070.07
-0.650.320.820.840.990.980.41-0.381.0-0.86-0.84-0.920.95-0.830.920.83-0.820.66-0.83-0.32-0.29-0.29
-0.330.670.970.810.860.880.5-0.240.83-0.78-0.85-0.90.69-0.780.770.83-0.850.29-0.84-0.7-0.28-0.28
0.25-0.24-0.79-0.65-0.8-0.86-0.170.66-0.850.971.00.95-0.810.98-0.94-0.82-0.85-0.521.00.67-0.12-0.12
-0.31-0.390.230.280.60.62-0.05-0.670.66-0.71-0.53-0.470.77-0.580.740.660.29-0.52-0.530.10.280.28
0.26-0.22-0.79-0.66-0.81-0.86-0.150.68-0.860.971.00.95-0.830.99-0.95-0.83-0.841.0-0.530.64-0.12-0.12
-0.14-0.52-0.66-0.26-0.3-0.45-0.250.21-0.350.520.640.57-0.150.55-0.44-0.32-0.70.670.10.64-0.01-0.01
0.66-0.69-0.37-0.46-0.31-0.29-0.68-0.74-0.26-0.18-0.120.15-0.05-0.180.07-0.29-0.28-0.120.28-0.12-0.011.0
0.66-0.69-0.37-0.46-0.31-0.29-0.68-0.74-0.26-0.18-0.120.15-0.05-0.180.07-0.29-0.28-0.120.28-0.12-0.011.0
Click cells to compare fundamentals

GeneDx Holdings Account Relationship Matchups

GeneDx Holdings income statement Accounts

202020212022202320242025 (projected)
Net Interest Income(2.0M)(2.8M)(666K)1.1M(3.0M)(2.9M)
Depreciation And Amortization14.1M23.4M63.0M33.7M38.8M30.9M
Interest Expense2.5M2.8M3.2M3.0M3.5M2.7M
Selling General Administrative100.7M206.0M203.3M133.8M101.1M142.0M
Selling And Marketing Expenses63.2M112.7M134.9M61.0M67.4M87.7M
Total Revenue179.3M212.2M234.7M202.6M305.5M243.9M
Gross Profit4.0M(16.6M)(26.8M)60.6M194.4M204.1M
Other Operating Expenses421.3M658.3M692.2M366.2M325.3M493.2M
Operating Income(242.0M)(446.1M)(667.7M)(163.7M)(23.2M)(24.4M)
Net Income From Continuing Ops(241.3M)(245.4M)(549.0M)(175.8M)(52.3M)(54.9M)
Ebit(238.9M)(242.6M)(461.2M)(170.2M)(153.2M)(160.8M)
Research Development72.7M105.2M86.2M58.3M45.7M53.7M
Ebitda(224.7M)(219.2M)(398.2M)(136.5M)(23.2M)(24.4M)
Cost Of Revenue175.3M228.8M261.4M141.9M111.1M137.6M
Total Operating Expenses246.0M429.5M430.8M224.3M214.2M304.0M
Reconciled Depreciation11.7M21.8M59.3M33.7M22.0M28.4M
Income Before Tax(241.3M)(245.4M)(598.0M)(176.7M)(52.6M)(55.3M)
Total Other Income Expense Net654K200.8M69.6M(13.0M)(29.4M)(27.9M)
Net Income(246.4M)(245.4M)(549.0M)(175.8M)(52.3M)(54.9M)
Income Tax Expense5.1M21.6M(49.1M)(926K)(343K)(360.2K)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for GeneDx Stock Analysis

When running GeneDx Holdings' price analysis, check to measure GeneDx Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeneDx Holdings is operating at the current time. Most of GeneDx Holdings' value examination focuses on studying past and present price action to predict the probability of GeneDx Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeneDx Holdings' price. Additionally, you may evaluate how the addition of GeneDx Holdings to your portfolios can decrease your overall portfolio volatility.